ITALY – Rome. San Camillo-Forlanini Uses Stem Cells to Reduce Organ Rejections

(Stem Cells News image)

location of Lazio region in Italy
Image via Wikipedia

The regional transplant center realized by the San Camillo-Forlanini Hospital along with the Spallanzani medical center is attempting to improve the efficiency of organ transplants with the use of stem cells removed from and used in the patient (autologous stem cells). The project designed by the Lazio based medical institutes is currently being used in experiments at the Ospedali Riuniti di Bergamo (United Hospitals of Bergamo). Rejection is the most frequent cause of kidney transplant failure. With current anti-rejection drugs, about 50% of kidney transplants stop functioning after about 10 years due to chronic rejection or the toxicity of the immunosuppressive therapies which favor tumor growth.

The objective of transplant medicine is to identify therapies that allow the transplanted organ to be tolerated. One possibility that could induce tolerance is tied to a new stem cell therapy. This technique consists of transplanting organs along with stem cells previously isolated from the bone marrow of the person receiving the transplant. These are some of the topics that will be discussed at the 3rd Course of Nephrology and Dialysis called ‘Kidney Transplants, Tumors, and Stem Cells’ including national and international experts taking place today, Friday November 28 at the Hotel Jolly Villa Carpegna.

2 thoughts on “ITALY – Rome. San Camillo-Forlanini Uses Stem Cells to Reduce Organ Rejections”

Leave a Reply

Your email address will not be published.

This site uses Akismet to reduce spam. Learn how your comment data is processed.